IP Library › Assignment 033179/0897
Patent Assignment
Reel/Frame 033179/0897

Assignment of Assignor's Interest

Recorded: 2014-06-10 Pages: 5
Assignor
THERAVANCE, INC.
Executed: 2014-06-01
Assignee
THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (6)
Process for Purifying Glycopeptide Phosphonate Derivatives
Patent: 7,015,307 →
Application: 10/226,676 →
Publication: US 2003/0119722
Process for Purifying Glycopeptide Phosphonate Derivatives
Patent: 7,375,181 →
Application: 11/301,740 →
Publication: US 2006/0100415
Process for Purifying Glycopertide Phosphonate Derivatives
Patent: 7,468,420 →
Application: 11/977,605 →
Publication: US 2008/0103290
Process for Purifying Glycopeptide Phosphonate Derivatives
Patent: 7,858,583 →
Application: 12/272,554 →
Publication: US 2009/0215673
Process for Purifying Glycopeptide Phosphonate Derivatives
Application: 12/947,686 →
Publication: US 2011/0257364
Process for purifying glycopeptide phosphonate derivatives
Application: 60/314,712 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 22, 2002
From: SCHMIDT, DONALD E., JR.; SGANGA, JEANMARIE DONOVAN
To: THERAVANCE, INC.
Reel/Frame 013010/0350 →
Assignment of Assignor's Interest Aug 23, 2002
From: SCHMIDT, DONALD E., JR.; SGANGA, JEANMARIE DONOVAN
To: THERAVANCE, INC.
Reel/Frame 013242/0755 →
Assignment of Assignor's Interest Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →